AdaptHealth Corp. (NASDAQ:AHCO) Shares Purchased by Quarry LP

Quarry LP increased its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 4,596.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,965 shares of the company’s stock after acquiring an additional 5,838 shares during the period. Quarry LP’s holdings in AdaptHealth were worth $67,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Intech Investment Management LLC grew its holdings in AdaptHealth by 223.2% during the third quarter. Intech Investment Management LLC now owns 59,650 shares of the company’s stock worth $670,000 after acquiring an additional 41,196 shares during the period. Victory Capital Management Inc. grew its holdings in AdaptHealth by 727.4% in the third quarter. Victory Capital Management Inc. now owns 141,507 shares of the company’s stock valued at $1,589,000 after purchasing an additional 124,404 shares during the period. Royce & Associates LP grew its holdings in AdaptHealth by 13.5% in the third quarter. Royce & Associates LP now owns 777,405 shares of the company’s stock valued at $8,730,000 after purchasing an additional 92,740 shares during the period. Segall Bryant & Hamill LLC grew its holdings in AdaptHealth by 15.5% in the third quarter. Segall Bryant & Hamill LLC now owns 3,701,808 shares of the company’s stock valued at $41,571,000 after purchasing an additional 496,453 shares during the period. Finally, Foundry Partners LLC grew its holdings in AdaptHealth by 60.5% in the third quarter. Foundry Partners LLC now owns 755,207 shares of the company’s stock valued at $8,481,000 after purchasing an additional 284,612 shares during the period. 82.67% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, COO Shaw Rietkerk sold 25,000 shares of the business’s stock in a transaction on Friday, September 20th. The stock was sold at an average price of $11.24, for a total transaction of $281,000.00. Following the completion of the transaction, the chief operating officer now directly owns 212,611 shares of the company’s stock, valued at $2,389,747.64. The trade was a 10.52 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 4.43% of the company’s stock.

Analyst Ratings Changes

AHCO has been the topic of several research analyst reports. UBS Group dropped their price objective on AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a report on Wednesday, November 6th. Royal Bank of Canada lowered their price target on AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 19th. Robert W. Baird lowered their price target on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 6th. Truist Financial lowered their price target on AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a research note on Friday, November 15th. Finally, Canaccord Genuity Group lowered their price target on AdaptHealth from $14.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, November 6th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $11.67.

AdaptHealth Stock Performance

Shares of AdaptHealth stock opened at $9.73 on Monday. AdaptHealth Corp. has a one year low of $6.43 and a one year high of $11.90. The company has a market cap of $1.31 billion, a price-to-earnings ratio of -5.90, a PEG ratio of 1.36 and a beta of 1.10. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The business’s 50 day moving average price is $10.27 and its 200 day moving average price is $10.46.

AdaptHealth (NASDAQ:AHCO) last posted its earnings results on Tuesday, November 5th. The company reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.02). AdaptHealth had a negative net margin of 6.57% and a positive return on equity of 9.62%. The business had revenue of $805.90 million during the quarter, compared to analysts’ expectations of $809.32 million. During the same quarter in the prior year, the firm earned $0.19 EPS. AdaptHealth’s revenue for the quarter was up .2% compared to the same quarter last year. On average, research analysts predict that AdaptHealth Corp. will post 0.88 EPS for the current year.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.